Could Low-Dose Ketamine Be a Treatment for ADNP Syndrome in Children?

Low-dose ketamine may be a viable treatment option for symptoms of activity-dependent neuroprotective protein syndrome in children.

Related Keywords

United States , ,Icahn School Of Medicine At Mount Sinai ,Human Genetics ,Icahn School ,Mount Sinai ,Sleep Habits Questionnaire ,Sensory Profile ,Behavior Checklist ,Mood Scales ,Behavior Scale Revised ,Strain Questionnaire ,Global Impression Scale ,Neurodevelopmental Disorders ,